NCT05878808 is a clinical trial of Psychometric assessment in Obsessions, sponsored by Cairo University.

Who is sponsoring NCT05878808?

NCT05878808 is sponsored by Cairo University.

What drugs are being tested in NCT05878808?

Interventions in NCT05878808: Psychometric assessment.

What condition does NCT05878808 study?

NCT05878808 studies Obsessions, Suicide, Bipolar I Disorder, Obsessive-Compulsive Disorder.

Is NCT05878808 still recruiting?

NCT05878808 is currently completed. Last updated 26 May 2023.

Last reviewed 2023-05-26 · How we verify

NCT05878808

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Obsessions and Suicidality in Youth With Bipolar 1 Disorder

Completed Last updated 26 May 2023

What this trial tests

trial testing Psychometric assessment in Obsessions in 80 participants. Completed in 5 January 2023.

Timeline

1 February 2022

Primary endpoint
15 September 2022

5 January 2023

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 February 2022
Primary completion	15 September 2022
Estimated completion	5 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

Psychometric assessment

Conditions studied

Obsessions — all drugs for Obsessions →
Suicide — all drugs for Suicide →
Bipolar I Disorder — all drugs for Bipolar I Disorder →
Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →

Sponsor

Cairo University

Who can join

Adults 15 to 24, any sex, with Obsessions or Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obsessive-compulsive disorder (OCD) is a common co-morbidity with bipolar I disorder, a comorbidity that is known to increase suicide risk. This study aimed to assess the presence of OCD in youth diagnosed with bipolar I disorder \& to evaluate the association between OCD and suicide in the same cohort. Eighty subjects diagnosed with bipolar I disorder were enrolled in this study, subjects were divided according to the presence or absence of OCD to Group A: Bipolar disorder patients with OCD (n = 26), Group B: Bipolar disorder patients without OCD (n = 54). The following scales were applied: Dimensional Yale-Brown obsessive compulsive scale (DYBOCS)- Beck scale for Suicidal ideations (BSSI) - Hamilton depression rating scale (HDRS) and Young mania rating scale (YMRS). The results revealed that DYBOCS score of group A was 30.23±0.43, \& of group B was 18.50±1.88 with a significant difference (p\<0.01). There was a significantpositive correlation between BSSI and age, age of onset and YMRS in Group A (p\<0.01). The study demonstrated that OCD is a common comorbidity in youth with bipolar I disorder and may be associated with a greater risk of suicide than in youth with bipolar I disorder without co-morbid OCD. Furthermore, co-morbidity of OCD with bipolar I disorder in youth may be associated with younger age of onset and more severe symptoms profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Psychometric assessment

Trials testing the same drug.

NCT02511483 — Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain · Phase 2 · terminated

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05878808 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 26 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05878808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing